Explore the first articles from RSC Pharmaceutics
We are delighted to share the first articles from RSC Pharmaceutics. Our new journal publishes crucial research on pharmaceutics, which has the potential to drive real change in worldwide health. Every article is gold open access, so you can read and be inspired for free.
 |
Dextrin conjugation to colistin inhibits its toxicity, cellular uptake and acute kidney injury in vivoMathieu Varache, Siân Rizzo, Edward J. Sayers, Lucy Newbury, Anna Mason, Chia-Te Liao, Emilie Chiron, Nathan Bourdiec, Adam Jones, Donald J. Fraser, Philip R. Taylor, Arwyn T. Jones, David W. Thomas and Elaine L. Ferguson RSC Pharm., 2024, Advance Article, |
Indocyanine green within glycosylated polymeric micelles as potential image agents to map sentinel lymph nodes and breast cancerNicole Lecot, Marcelo Fernández-Lomónaco, Hugo Cerecetto, Juan Pablo Gambini, Pablo Cabral and Romina Glisoni RSC Pharm., 2024, Advance Article, |
 |
 |
A zuranolone nanocrystal formulation enables solubility-independent in vivo study of pentylenetetrazol-induced seizures in a rat modelStanislav Chvíla, Hana Kubová, Pavel Mareš, Eva Kudová and František Štěpánek RSC Pharm., 2024, Advance Article, |
These articles and our future publications are free to access by anyone.
Start reading now
|
|
RSC Pharmaceutics provides researchers with a platform to publish research in pharmaceutics and advance this field. We are interested in any submission that shares new scientific findings across chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery. |
